Early spatiotemporal characterization of microglial activation in the retinas of rats with streptozotocin-induced diabetes

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 253, Issue 4, 2015, Pages 519-525

  Chen, Xiaofei ^a   Zhou, Huanfen ^a   Gong, Yan ^a   Wei, Shihui ^a   Zhang, Maonian ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Diabetic retinopathy; Glial activation; Microglia; Neuropathology

Indexed keywords

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY LABELING; ARTICLE; BODY WEIGHT; CELL ACTIVATION; CELL DENSITY; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; MALE; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINA NERVE CELL; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; DIABETIC RETINOPATHY; ENZYME IMMUNOASSAY; EXPERIMENTAL DIABETES MELLITUS; GENETICS; METABOLISM; NERVE FIBER; OPTIC NERVE DISEASE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; WISTAR RAT;

ACTIN BINDING PROTEIN; AIF1 PROTEIN, RAT; CALCIUM BINDING PROTEIN; CD11B ANTIGEN; GLUCOSE BLOOD LEVEL; MESSENGER RNA; STREPTOZOCIN;

ANIMALS; ANTIGENS, CD11B; BLOOD GLUCOSE; CALCIUM-BINDING PROTEINS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; IMMUNOENZYME TECHNIQUES; MACROPHAGE-1 ANTIGEN; MALE; MICROFILAMENT PROTEINS; MICROGLIA; NERVE FIBERS; OPTIC NERVE DISEASES; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; STREPTOZOCIN;

EID: 84925240067     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-014-2727-y     Document Type: Article

References (35)

1. Moss S, Klein R, Klein B (1998) The 14-year incidence of visual loss in a diabetic population. Ophthalmology 105:998–1003
2. Bunce C, Xing W, Wormald R (2010) Causes of blind and partial sight certifications in England and Wales: April 2007-March 2008. Eye (Lond) 24:1692–1699
3. Gardner T, Antonetti D, Barber A, LaNoue K, Levison S (2002) Diabetic retinopathy: more than meets the eye. Surv Ophthalmol 47(Suppl 2):S253–S262
4. Fletcher E, Phipps J, Wilkinson-Berka J (2005) Dysfunction of retinal neurons and glia during diabetes. Clin Exp Optom 88:132–145
5. Kern T (2007) Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res 2007:95103
6. Kim Y, Joh T (2006) Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson’s disease. Exp Mol Med 38:333–347
7. Zeng H, Green WR, Tso MOM (2008) Microglial activation in human diabetic retinopathy. Arch Ophthalmol 126:227–232
8. Rungger–Brändle E, Dosso AA, Leuenberger PM (2000) Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci 41:1971–1980
9. Gaucher D, Chiappore J-A, Pâques M, Simonutti M, Boitard C, Sahel J, Massin P, Picaud S (2007) Microglial changes occur without neural cell death in diabetic retinopathy. Vis Res 47:612–623
10. Zeng X, Y-k NG, E-a L (2000) Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Vis Neurosci 11:463–471
11. Moss A, Beggs S, Vega-Avelaira D, Costigan M, Hathway G, Salter M, Fitzgerald M (2007) Spinal microglia and neuropathic pain in young rats. Pain 128:215–224
12. Sandhir R, Onyszchuk G, Berman N (2008) Exacerbated glial response in the aged mouse hippocampus following controlled cortical impact injury. Exp Neurol 213:372–380
13. Robinson A, White T, Mason D (1986) Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRS OX-42, the latter recognising complement receptor type 3. Immunology 57:239–247
14. Davis E, Foster T, Thomas W (1994) Cellular forms and functions of brain microglia. Brain Res Bull 34:73–78
15. Raibon E, Sauvé Y, Carter D, Gaillard F (2002) Microglial changes accompanying the promotion of retinal ganglion cell axonal regeneration into peripheral nerve grafts. J Neurocytol 31:57–71
16. Hanisch U, Kettenmann H (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10:1387–1394
17. Streit W (2002) Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40:133–139
18. Krady J, Basu A, Allen C, Xu Y, LaNoue K, Gardner T, Levison S (2005) Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 54:1559–1565
19. Arnal E, Miranda M, Johnsen-Soriano S, Alvarez-Nölting R, Díaz-Llopis M, Araiz J, Cervera E, Bosch-Morell F, Romero FJ (2009) Beneficial effect of docosahexanoic acid and lutein on retinal structural, metabolic, and functional abnormalities in diabetic rats. Curr Eye Res 34:928–938
20. Qiao H, Hisatomi T, Sonoda K, Kura S, Sassa Y, Kinoshita S, Nakamura T, Sakamoto T, Ishibashi T (2005) The characterisation of hyalocytes: the origin, phenotype, and turnover. Br J Ophthalmol 89:513–517
21. Marie O, Thillaye-Goldenberg B, Naud M, de Kozak Y (1999) Inhibition of endotoxin-induced Uveitis and potentiation of local TNF-a and interleukin-6 mRNA expression by interleukin-13. Invest Ophthalmol Vis Sci 40:2275–2282
22. Ohsawa K, Kohsaka S (2011) Dynamic motility of microglia: purinergic modulation of microglial movement in the normal and pathological brain. Glia 59:1793–1799
23. Ibrahim A, El-Remessy A, Matragoon S, Zhang W, Patel Y, Khan S, Al-Gayyar M, El-Shishtawy M, Liou G (2011) Retinal microglial activation and inflammation induced by amadori-glycated albumin in a rat model of diabetes. Diabetes 60:1122–1133
24. Hanisch U (2002) Microglia as a source and target of cytokines. Glia 40:140–155
25. Zeng H, Zhu X, Zhang C, Yang L, Wu L, Tso M (2005) Identification of sequential events and factors associated with microglial activation, migration, and cytotoxicity in retinal degeneration in rd mice. Invest Ophthalmol Vis Sci 46:2992–2999
26. Kowluru R, Odenbach S (2004) Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants. Invest Ophthalmol Vis Sci 45:4161–4166
27. Demircan N, Safran B, Soylu M, Ozcan A, Sizmaz S (2006) Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye (Lond) 20:1366–1369
28. Kitaoka Y, Kitaoka Y, Kwong J, Ross-Cisneros F, Wang J, Tsai R, Sadun A, Lam T (2006) TNF-alpha-induced optic nerve degeneration and nuclear factor-kappaB p65. Invest Ophthalmol Vis Sci 47:1448–1457
29. Berger S, Savitz S, Nijhawan S, Singh M, David J, Rosenbaum P, Rosenbaum D (2008) Deleterious role of TNF-alpha in retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 49:3605–3610
30. Morgan S, Taylor D, Pocock J (2004) Microglia release activators of neuronal proliferation mediated by activation of mitogen-activated protein kinase, phosphatidylinositol-3-kinase/Akt and delta-Notch signalling cascades. J Neurochem 90:89–101
31. YZ L, CH L, FC C, CM H (2005) Molecular mechanisms responsible for microglia-derived protection of Sprague–Dawley rat brain cells during in vitro ischemia. Neurosci Lett 373:159–164
32. Yune T, Lee J, Jung G, Kim S, Jiang M, Kim Y, Oh Y, Markelonis G, Oh T (2007) Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury. J Neurosci 27:7751–7761
33. Wang A, Yu A, Lau L, Lee C, Wu M, Zhu X, Tso M (2005) Minocycline inhibits LPS-induced retinal microglia activation. Neurochem Int 47:152–158
34. Chen M, Ona V, Li M, Ferrante R, Fink K, Zhu S, Bian J, Guo L, Farrell L, Hersch S, Hobbs W, Vonsattel J, Cha J, Friedlander R (2000) Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6:797–801
35. Wang J, Wei Q, Wang C, Hill W, Hess D, Dong Z (2004) Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria. J Biol Chem 279:19948–19954